Agilis Robotics has designed and developed fully flexible robotic instruments for endoluminal surgery with cutting edge mechanical architecture. The robotic system is able to seamlessly integrate into current clinical workflows and drastically reduce the learning curve associated with endoscopic surgery. Through the flexible operation altogether with the fully flexible robotic arm, the entire tumour tissue can be effectively removed, especially for early stage cancers of the gastrointestinal tract and urinary tract. The company’s ultimate goal is to provide clinicians with the next-generation of minimally invasive instruments for more effective and affordable early stage care for patients.
Agilis Robotics has kickstarted its first trial in mainland China, taking a great leap forward in robotized endoscopic surgery in the country
2023-03-21 PR Newswire
Agilis Robotics has just kickstarted its series of pre-clinical tests in mainland hospitals and is set to initiate First-in-Human (FIH) testing in 2024.
Agilis Robotics Completes New Round of Live Animal Trials with Miniaturized Robotic Instruments for Endoscopic Surgery
2023-01-17 PR Newswire
Agilis Robotics, a leading developer of flexible robotic instruments that support endoscopic surgery through natural orifices of the body (e.g. along the gastrointestinal tract and in the bladder), has recently completed the second round of live animal testing using its proprietary robot.
Agilis Robotics conducts first live animal trial for GI indication, targeting 510(k) clearance by 2025 to transform endoscopic surgery
2023-04-19 PR Newswire
Agilis Robotics has recently showcased the system's capabilities in a trial performed on a live pig subject at The University of Hong Kong-Shenzhen Hospital in March. Dr Joe FAN King Man led the trial and successfully performed endoscopic submucosal dissection (ESD) in the upper and lower gastrointestinal tract with the robotic system.